help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on April 24, 2003
Endocrinology, doi:10.1210/en.2002-0092
A more recent version of this article appeared on August 1, 2003
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
144/8/3469    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alarid, E. T.
Right arrow Articles by Solodin, N. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alarid, E. T.
Right arrow Articles by Solodin, N. M.

Submitted on December 2, 2002
Accepted on April 16, 2003

Thyroid hormone is an inhibitor of estrogen-induced degradation of ER{alpha} protein: estrogen-dependent proteolysis is not essential for receptor transactivation function in the pituitary

Elaine T. Alarid1*, Mara T. Preisler-Mashek1, and Natalia M. Solodin1

1 Department of Physiology, University of Wisconsin, Madison, WI 53706

* To whom correspondence should be addressed. E-mail: alarid{at}physiology.wisc.edu.

Proteolysis by the 26S proteasome is an important regulatory mechanism that governs the protein stability of several steroid/nuclear receptors and that has been implicated in the control of receptor transcriptional activation function. Herein, we report that thyroid hormone can prevent estrogen-induced proteolysis of ER{alpha} protein in lactotrope cells of the pituitary. The stabilization of ER{alpha} protein by thyroid hormone represents a selective blockade against estradiol-stimulated degradation since thyroid hormone, but not glucocorticoid, can protect estrogen-activated ER{alpha}. Moreover, thyroid hormone treatment does not interfere with signal-induced proteolysis of a separate proteasome target, I{kappa}B{alpha} or ER{alpha} proteolysis induced by ICI182780. Using thyroid hormone as a tool to inhibit ER{alpha} proteolysis, we examined the effect of loss of this regulatory function on estrogen-induced transcriptional responses. Consistent with earlier reports, estrogen activation of an idealized ERE reporter gene was inhibited. However, thyroid hormone did not prevent induction of prolactin gene expression or the ability of ER{alpha} to stimulate proliferation. These results demonstrate that estrogen-induced proteolysis of ER{alpha} is not a general requirement for receptor transcriptional activation function, and they demonstrate that proteolytic regulation is a means by which other endocrine factors can indirectly modulate ER{alpha} activity.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society